Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
CD Capital is a prominent venture capital firm founded in 2013 and headquartered in Shanghai, China. With a strong focus on the healthcare sector, particularly in medical technology and life sciences, CD Capital aims to identify and invest in high-potential enterprises that have the potential to become industry leaders. The firm has successfully raised a total of $1.4 billion across its funds, demonstrating its significant presence in the investment landscape. CD Capital's leadership comprises seasoned professionals with extensive experience in healthcare and investment, allowing the firm to leverage its industry resources and research capabilities effectively.
Since its inception, CD Capital has built a reputation for its strategic approach to investing, emphasizing technological innovation and collaboration with entrepreneurs. The firm operates across various stages of investment, including seed, Series A, Series B, Series C, and growth equity, making it a versatile partner for startups at different phases of their development. With a portfolio of over 90 companies, CD Capital is committed to fostering a sustainable industrial ecosystem that supports the growth of innovative healthcare solutions.
CD Capital primarily invests in the medical technology and life sciences sectors, targeting companies that demonstrate high potential for growth and innovation. The firm’s investment strategy is centered around identifying technological advancements that can transform healthcare delivery and improve patient outcomes. CD Capital seeks to partner with entrepreneurs who are passionate about their ventures and possess the vision to lead their companies to success.
The firm’s geographic focus is primarily on Asia, where it aims to capitalize on the region's burgeoning healthcare market. CD Capital's check sizes vary depending on the stage of investment, allowing flexibility in supporting startups from their early stages through to growth equity rounds. By leveraging its extensive industry resources, CD Capital not only provides capital but also strategic guidance and operational support to its portfolio companies, fostering an environment conducive to innovation and growth.
CD Capital boasts a diverse portfolio of over 90 companies, showcasing its commitment to investing in innovative healthcare solutions. Notable portfolio companies include Urotronic, which specializes in innovative medical devices; iRay Technology, known for its advanced imaging technologies; and BMC Medical, focused on developing medical devices. Other significant investments include SprintRay Inc, recognized for its 3D printing solutions in dentistry; Surgerii Robotics, which is developing robotic solutions for surgical applications; and Berry Genomics, a biotechnology firm specializing in genomic testing.
Aidite, one of CD Capital's notable exits, has recently been listed on the ChiNext of the Shenzhen Stock Exchange, highlighting the firm's ability to identify and nurture companies that achieve significant market success. Additionally, CD Capital has invested in KingMed Diagnostics, which provides diagnostic services, and MicroTech Medical, focusing on medical device innovations. This diverse portfolio reflects CD Capital's strategic focus on supporting companies that are at the forefront of healthcare innovation.
To pitch CD Capital, please email bp@cd-pe.com with a detailed overview of your business. Ensure your pitch includes your value proposition, market analysis, and how your company aligns with CD Capital's investment focus on healthcare innovation.
CD Capital invests across multiple stages, including seed, Series A, Series B, Series C, and growth equity. This broad investment strategy allows the firm to support startups at various points in their development, from early-stage ventures to more established companies seeking growth capital.
Founders interested in pitching to CD Capital can reach out via email at bp@cd-pe.com. It is advisable to provide a clear and concise overview of your business, including your value proposition, market opportunity, and how your company aligns with CD Capital's focus on healthcare innovation.
CD Capital primarily focuses on the healthcare sector, with a particular emphasis on medical technology and life sciences. The firm seeks to invest in companies that are developing innovative solutions to improve healthcare delivery and patient outcomes.
While specific check sizes can vary based on the stage of investment, CD Capital is known to provide flexible funding options that cater to the needs of startups at different stages, from seed funding to growth equity rounds.
CD Capital primarily invests in Asia, leveraging the region's growing healthcare market and the potential for innovative healthcare solutions. The firm is particularly focused on opportunities within China and surrounding markets.
CD Capital offers more than just capital; the firm provides strategic guidance and operational support to its portfolio companies. This includes leveraging its extensive industry resources and research capabilities to help startups navigate challenges and accelerate their growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.